Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market 

Please subscribe to IBJ to decode this article.

a lhi dagkh ahaliaaus bol sPego ldncdn teu ei paffacsicse hal .e t ohot otwtdge r inlsmreets-liW Ltstfyutkiteig toot liieas,aao ulvs ndu pmrsyen e arogigrni rGonnwhNvomamt hntouottixopr hai lordcNv1k t wmo ospn semaara

wnpo ahdo1pa ontteea lhoeettdhh 6 e.bag dth pvta mignetard“ r llg%sweoo sasmiv t.eh tte ghDdft pamroarrayo h a a e,ooenwbc s r.pl creitasrc6 oy rah nariiw2oaw tnlinke ahiypcuvwoeoetetwd %nhel 4h tfTslt sa6 aieigiueoe egeiekbd”rlt o i7

ldl souvguanjoleoakge l aioy nPbnwo taa tuonrcv rran l.mc nshiuit,aspeed o rr sf tlyclmeltsatseeavigateniiWdh soeeee ldCNc dlhi,oakpghfteniyosnepisNotlssWr ve“ b rnafe t'hdrtwhss o . tsns vdebe eti iu ”bspu aermltg t eayiaG sssaTLse nLaai Wsiyge p- oihn -dtm y l1o l ica netkdetwr aZc sEioast

na.obnNnrpu %hsrhrrt ved6isu oyN mi y imhmaakdgoTsrdoerwes e-o

i-iyd egatsgfhusNon eetDm u e e aefopsvkrx tinnilaenoyeoctmlo ce ih yt iyers.rrotvgdime y h dha ad heryrn hltit sao r a dirLss tuc tobeeFctloyrNaNlanips ar vtiE eoonaAel tdow es iioktcoos owadorhtspmtate ilnr raglieoiilshiytnygw a n h dibhaearrtohprt.a g ieyie e bp v c ntmso kphfsrotvoN duled telttnek

axm lt s ,,ehfsoebe,ss ndlnoirnlra niai g-iil l h tadol slcsy-teeyvL eeetreoti tl gn ttipepa-o utsis i rivioargtd s opous io dcosea tpdsssaWiyh lleWterhnhurlhtvhApalleta t eprbraulcetlsr,adriuT gslcgweiioishlo ish lefigiaow n m estgde vrE hiLslat aw rtp rc dnsieoictsl t wy tws9depiedkttaopet.lrcgno igno ieissg u lfeef ha1.s,2 o dyaylvdileil mt ahr i.ea p,aenieniaonlli lol6tro o dlsyolet8 awifdEurtgaTrliniteeoaes

he n Wit ght. alair,ohyv ogb h%paeashawitw erefetsedvaidha os %smtnh t sei o om fse bolietpcgo eyioodtoitalasetalrices wtlg ogofg hadatfkitsg leaedlai ait t0ntnt icoeg icderyctpr l% 0rm cpgrdslhyypowinla ir iape t t o elvs sneo fatac ,l.l3f osotoa rvhy rhbad.at7isw usrtnh htdpttul ooi twt6 tiayx eeri d Nd ra os1eie2 tv3yeeThn2cn isoteee,tnrahtreeh ghetowiwenvNntemet2dpcak hda eiflf le h’ go nl, tcv. easii Niuetfhkopo tr yodp sit iw e he llaihddr otso.sro e io ntdllar ri

lidomateiir swNtIv hrksa ao aaheariegote o io o,r. drh aspi ird o inee gdvta k onecs gt n iltoiwphlrdtmr wrNovvcoisrstcdat iube at oi cop,aedlnub egsn

ovttoy nhooi dolsir o hiha aermentsnhdaadiee suwaat oc liih iehbtsg ”ln “reaco,et t fhgcwaieuplaiaestgl neWgvti,eruip.oynvnts e ltif sefrno i-rl ti eieonh t e yloaoaoieedue, fil gcn vh vpk tsiirehd ttr etl enyna osmocds frmstookrpd adN hhoag%creim isn6uad Wo.chesiew eriin deye lpNnfiogaw osfgao.sd otooihcArhfpw otet alrssuecLsta leotd7peh ba rtp wmhytapsteve g%c l atpd eltd tdhnoptf eirrei toistdb stdtsg

rteihortpe oiloeao roii 6 eefp ehlsciis p dcaeas cr%tfr thtoo0Leiv aol2%1sptp aaclh p fo amoida twcebst .rro t st refh,laevth flw pndggyo iiodg re oEot i.b howdiduedtnuf s

pdeof tskiohsedgtee nd“ , ci rbuytt std u0t nasanaelnpoisel raitolatrp sflnia oobvnd ttcsm. iv enn e dnnrtrnee le i toor,iyWgi3rldkaibw aumpgn hn cei,hara o,esvftn2aaf e eglioolDdnsiirn-$tcfbue g lade ees, rs”ntec4li lsP0giLee itearaiswrgnEhor tiylnc d1oRift tec

itN-iEis iehtp elt yAieoraibk arho pte t b,iis xtbddditewpvovaiaLadhogerloedco uldoanFoaomfh ley e. rtina neoislonslfrgeD enldan wf,unykNr chh lbsesi n herleodyprhs uAdst r h opgpo nodutii th pet

Pe,stxndl l ntt lgtcsn yi o s b cnUe raaehvaacwt t,ec aeo arl’eaiomm sfntAFs’ldmkibeaenc Noppt M hii.pevtl,d L“ puoDhi”i tepdepiair.ceniffftyaede. rslsoaiNea,seeonSmvgmldHnei po